About Ceapro

Ceapro Inc. engages in the development and marketing of various health and wellness products and technology relating to plant extracts. The company has a license agreement with the University of Alberta for the rights to a technology that would allow the development, production, and commercialization of powder formulations that could be used as active ingredients for all industrial applications. Segments The company operates through two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry. Active Ingredient Product Technology Industry This segment engages in the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include the company’s value drivers, Oat Beta Glucan and Avenanthramides. These and similar manufactured products are sold primarily through distribution networks. Cosmeceutical Industry This segment involves the development and commercialization of anti-aging products derived from natural active ingredients and is represented in the company through its subsidiary, JuventeDC Inc. This line of value finished products is sold directly to the end user primarily through Website sales online and also through select natural stores. Research Collaboration As of August 23, 2021 Ceapro Inc. announced it has established a formal research collaboration with Angiogenesis Foundation. History Ceapro Inc. was founded in 1997. The company was incorporated in 1997.